Related Experiment Video
Updated: Jun 22, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
[Geriatric oncology: epidemiological evidence].
François Piette1, Jean-Philippe Spano, Pascal Chaibi
1Service de médecine interne, Hôpital Charles Foix, Université et Faculté de médecine Pierre et Marie Curie, F-94200 Ivry-sur-Seine, France. francois.piette@cfx.aphp.fr
Presse Medicale (Paris, France : 1983)
|June 23, 2009
Summary
Elderly patients over 65 account for most cancer cases and deaths in Europe. Research and care must address age-related factors like late diagnosis and comorbidity for better cancer treatment outcomes.
Area of Science:
- Geriatric oncology
- Cancer epidemiology in aging populations
Context:
- In Europe, individuals over 65 represent 60% of cancer diagnoses and 75% of cancer-related mortality.
- Cancer incidence, particularly for prostate, colorectal, breast, lung, and hematological malignancies, is notably high in older adults.
- Key challenges in elderly cancer care include late diagnosis and the presence of comorbidities, necessitating specialized geriatric assessments.
Purpose:
- To highlight the unique challenges and considerations for treating cancer in elderly patients.
- To advocate for research focusing on age-specific cancer characteristics and treatment responses.
- To emphasize the need for integrated geriatric and oncologic care models.
Summary:
- Cancer significantly impacts the elderly population in Europe, with a high burden of disease and mortality.
- Late diagnosis and comorbidity are critical factors influencing cancer management in older adults.
- Geriatric assessment and multidisciplinary collaboration between oncologists and geriatricians are essential for optimal patient care.
Impact:
- Promotes a shift towards age-sensitive cancer research and clinical practice.
- Underscores the importance of equitable access to high-quality cancer care for all age groups.
- Encourages the development of tailored treatment strategies considering functional status and comorbidities in elderly cancer patients.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...